ESC Professional Premium Access

Cardioprotective pharmacotherapy in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study

Congress Presentation

About the speaker

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
29 presentations

6 more presentations in this session

Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on markers of neurohumoral activation and left atrial strain.

Speaker: Doctor I. Ikonomidis (Athens, GR)


Incident cardiovascular disease in women with type 1 or type 2 diabetes by history of hypertensive disorders of pregnancy

Speaker: Associate Professor S. Timpka (Malmo, SE)


Change in hbA1c following treatment with and the short-term risk of major adverse cardiovascular outcomes

Speaker: Mrs B. Zareini (Copenhagen, DK)


The prognostic value of high-sensitivity cardiac troponin t in diabetes patients without coronary artery disease

Speaker: Mr Y. He (Guangzhou, CN)


Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment.

Speaker: Doctor I. Ikonomidis (Athens, GR)


Access the full session

Diabetes and the heart (1)

Speakers: Professor S. Verma, Doctor I. Ikonomidis, Associate Professor S. Timpka, Mrs B. Zareini, Mr Y. He...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb